ArticleScientific reports2025
Lightweight hybrid transformers-based dyslexia detection using cross-modality data.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Identification of Comorbidities in Obstructive Sleep Apnea Using Diverse Data and a One-Dimensional Convolutional Neural Network.Sensors (Basel, Switzerland) · 2026Observational
- Electroencephalography-Based Machine Learning for Biomarker Detection in Dyslexia and Autism Spectrum Disorder: A Comparative Review of Models, Features, and Diagnostic Utility.Diagnostics (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Early and precise diagnosis of dyslexia is crucial for implementing timely intervention to reduce its effects. Timely identification can improve the individual's academic and cognitive performance. Traditional dyslexia detection (DD) relies on lengthy, subjective, restricted behavioral evaluations and interviews. Due to the limitations, deep learning (DL) models have been explored to improve DD by analyzing complex neurological, behavioral, and visual data. DL architectures, including convolutional neural networks (CNNs) and vision transformers (ViTs), encounter challenges in extracting meaningful patterns from cross-modality data. The lack of model interpretability and limited computational power restricts these models' generalizability across diverse datasets. To overcome these limitations, we propose an innovative model for DD using magnetic resonance imaging (MRI), electroencephalography (EEG), and handwriting images. We introduce a model, leveraging hybrid transformer-based feature extraction, including SWIN-Linformer for MRI, LeViT-Performer for handwriting images, and graph transformer networks (GTNs) with multi-attention mechanisms for EEG data. A multi-modal attention-based feature fusion network was used to fuse the extracted features in order to guarantee the integration of key multi-modal features. We enhance Dartbooster XGBoost (DXB)-based classification using Bayesian optimization with Hyperband (BOHB) algorithm. In order to reduce computational overhead, we employ a quantization-aware training technique. The local interpretable model-agnostic explanations (LIME) technique and gradient-weighted class activation mapping (Grad-CAM) were adopted to enable model interpretability. Five public repositories were used to train and test the proposed model. The experimental outcomes demonstrated that the proposed model achieves an accuracy of 99.8% with limited computational overhead, outperforming baseline models. It sets a novel standard for DD, offering potential for early identification and timely intervention. In the future, advanced feature fusion and quantization techniques can be utilized to achieve optimal results in resource-constrained environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.